Menu
Recruiting NCT06939387

Drug-induced Kidney Injury Model

Observational Acute Kidney Injury

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Observational study, no intervention.
Who it may be relevant to
Registry conditions: Acute Kidney Injury. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Establishment, Evaluation and Treatment Strategy of Drug-induced Kidney Injury Model

Overview

To establish the prediction model of renal dysfunction in patients with drug-induced renal injury and study the prognosis of different drug treatments

Interventions

  • Other Observational study, no intervention
    Observational study, no intervention

Primary outcome measures

  • Model performance metrics assessed by AUC-ROC, accuracy and F1-score using 10-fold cross-validation [Time frame: through study completion, an average of 6 months]
Secondary outcome measures (1)
  • The rate at which creatinine falls [Time frame: 7 days, 1 month, 3 months after treatment]

Eligibility criteria

Inclusion criteria

  • Drug-induce acute kidney injury

Exclusion criteria

  • 1.Dialysis patients; 2.No baseline creatinine; 3.Obstructive AKI; 4.Clinical data were incomplete.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Zhejiang Provincial People's Hospital — Hangzhou

Identifiers

NCT: NCT06939387 · KT2024116

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗